Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
Why Is ChemoCentryx (CCXI) Up 1.4% Since Last Earnings Report?
12:48pm, Wednesday, 07'th Sep 2022
ChemoCentryx (CCXI) reported earnings 30 days ago. What's next for the stock?
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ONEM, CCXI, AERI, SFT
11:26am, Thursday, 25'th Aug 2022
NEW YORK , Aug. 25, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences
08:30am, Wednesday, 24'th Aug 2022
SAN CARLOS, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced planned poster presentations at three upcoming medical conferences taking place in August and
Here's Why ChemoCentryx (CCXI) is a Great Momentum Stock to Buy
01:33pm, Tuesday, 16'th Aug 2022
Does ChemoCentryx (CCXI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Get ready for more merger mania in pharma sector the rest of the year
02:43pm, Tuesday, 09'th Aug 2022
Pfizer Inc.'s PFE, +0.24% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, +0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking.
Shareholder Alert - The M&A Class Action Firm Announces the Investigation of ChemoCentryx, Inc. - CCXI
01:58pm, Tuesday, 09'th Aug 2022
NEW YORK , Aug. 9, 2022 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rat
ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call
08:30am, Tuesday, 09'th Aug 2022
SAN CARLOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the cancellation of its second quarter 2022 financial results conference call scheduled for Tu
ChemoCentryx (CCXI) Moves 109.2% Higher: Will This Strength Last?
09:02am, Friday, 05'th Aug 2022
ChemoCentryx (CCXI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
ChemoCentrix Spikes 110% on Amgen Acquisition Deal
06:10pm, Thursday, 04'th Aug 2022
On Thursday, shares of ChemoCentryx Inc. ( CCXI , Financial) shot up more than 110% before closing the day at $50.43 on the news that the small-cap biotech company has entered into an agreement to be
SHAREHOLDER ALERT: Weiss Law Investigates ChemoCentryx, Inc
04:45pm, Thursday, 04'th Aug 2022
NEW YORK, Aug. 4, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of ChemoCentryx, Inc. ("ChemoCentryx" or the
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating ChemoCentryx, Inc. Buyout
03:21pm, Thursday, 04'th Aug 2022
Wilmington, Delaware--(Newsfile Corp. - August 4, 2022) - Rigrodsky Law, P.A. is investigating ChemoCentryx, Inc. ("ChemoCentryx") (NASDAQ: CCXI) regarding possible breaches of fiduciary duties and ot
ChemoCentryx Shares Are Jumping 110% Thursday: Here's Why
12:18pm, Thursday, 04'th Aug 2022
Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. Why Is It Moving?
ChemoCentryx (CCXI) Stock Soars 100% on Amgen Acquisition
11:30am, Thursday, 04'th Aug 2022
Source: Shutterstock ChemoCentryx (NASDAQ: CCXI ) stock is rocketing higher on Thursday as investors react to news of an acquisition deal with Amgen (NASDAQ: AMGN ). This deal has Amgen agreeing to ac
Shareholder Alert: Ademi LLP investigates whether ChemoCentryx, Inc. has obtained a Fair Price in its transaction with Amgen
11:18am, Thursday, 04'th Aug 2022
MILWAUKEE , Aug. 4, 2022 /PRNewswire/ -- Ademi LLP is investigating ChemoCentryx (NASDAQ: CCXI) for possible breaches of fiduciary duty and other violations of law in its transaction with Amgen. Cl
Why Amgen (AMGN) Is Buying ChemoCentryx (CCXI) For $4 Billion In Cash
10:39am, Thursday, 04'th Aug 2022
Amgen (AMGN) is buying ChemoCentryx (CCXI) for $4 billion in cash. These are the details.
